Comments on NASDAQ Rulemaking

Self-Regulatory Organizations; The Nasdaq Stock Market LLC; Notice of Filing of Proposed Rule Change to Adopt a New Continued Listing Requirement

Comments have been received from individuals and entities using a variety of Letter Types:

Comment
A: 261
B: 7
C: 9

Filter comments

Date Received
Date Sort descending Letter Type Commenter Name
Public Comment John Zecca, Nasdaq, Inc.
Public Comment Joseph D. Wilson, Bevilacqua PLLC
Public Comment Katie Kolchin, CFA, Managing Director, Head of Equity & Options Market Structure SIFMA; and Gerald O’Hara
Vice President & Assistant General Counsel SIFMA
Public Comment Keith Murphy, Executive Chairman, VivoSim Labs
Public Comment Marc Indeglia, President, Small Public Company Coalition; Jeffrey M. Harris Cody Ray Milner, Consovoy McCarthy PLLC; and Tyler R. Green,
Consovoy McCarthy PLLC
Public Comment Stephen John Berger, Managing Director, Global Head of Government and Regulatory Policy, Citadel Securities
Public Comment Sullivan & Worcester LLP
Public Comment Sumitaka Yamamoto, CEO, HeartCore Enterprises, Inc.
Public Comment Harter Secrest & Emery LLP
Public Comment James Foster, Chief Executive Officer, Virax Biolabs Group Limited
Public Comment Jeffrey Frelick, CEO, Bone Biologics Corporation
Public Comment Walter Klemp, Chairman and Chief Executive Officer, Moleculin Biotech, Inc.
Public Comment Michael Winston, Executive Chairman and Interim Chief Executive Officer, Jet.AI Inc.
Public Comment Pete Ricketts, United States Senator
Public Comment David A. Donohoe, Jr., DonohoeAdvisoryAssociates, LLC
Public Comment Joseph Wilson, Bevilacqua PLLC
Public Comment Marc Indeglia, The Small Public Company Coalition
Public Comment Michael Messinger, Chief Financial Officer, SeaStar Medical
Public Comment Sullivan & Worcester LLP
Public Comment Anthony Diamandis
Public Comment Brian L. Ross, Partner, Graubard Miller
Public Comment David R. Burton, Senior Research Fellow, Advancing American Freedom
Public Comment James Foster, Chief Executive Officer, Virax Biolabs Group Limited
Public Comment John Zecca, EVP and Chief Legal Officer, The Nasdaq Stock Market LLC
Public Comment Maggie Schroeder
Public Comment Stephen John Berger, Managing Director, Global Head of Government and Regulatory Policy, Citadel Securities
Public Comment Anonymous
Public Comment Marc Indeglia, The Small Public Company Coalition
Public Comment Ravi Chandra Gaddan
Public Comment Trena Hedges
File Number
SR-NASDAQ-2026-004
Release Number
34-104688